Exclusive

Publication

Byline

Location

US Patent Issued to EXELIXIS on July 14 for "PD-L1 binding agents and uses thereof" (Wisconsin, California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,893, issued on July 14, was assigned to EXELIXIS INC. (Alameda, Calif.). "PD-L1 binding agents and uses thereof" was invented by Bryan Glas... Read More


US Patent Issued to Cullinan Mica on July 14 for "Anti-MICA/B antibodies that block MICA/B shedding and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,894, issued on July 14, was assigned to Cullinan Mica Corp (Cambridge, Mass.). "Anti-MICA/B antibodies that block MICA/B shedding and metho... Read More


US Patent Issued to Bio-Thera Solutions on July 14 for "Recombinant antibody having unique glycan profile produced by CHO host cell with edited genome and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,895, issued on July 14, was assigned to Bio-Thera Solutions Ltd. (Guangzhou, China). "Recombinant antibody having unique glycan profile pro... Read More


US Patent Issued to PIERRE FABRE MEDICAMENT on July 14 for "Anti-cMET antibody" (French Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,896, issued on July 14, was assigned to PIERRE FABRE MEDICAMENT (Boulogne-Billancourt, France). "Anti-cMET antibody" was invented by Lilian... Read More


US Patent Issued to GALAXY BIOTECH on July 14 for "Monoclonal antibodies to fibroblast growth factor receptor 2" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,897, issued on July 14, was assigned to GALAXY BIOTECH LLC (Cupertino, Calif.). "Monoclonal antibodies to fibroblast growth factor receptor... Read More


US Patent Issued to CYTOMX THERAPEUTICS on July 14 for "Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof" (California, Colorado Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,898, issued on July 14, was assigned to CYTOMX THERAPEUTICS INC. (South San Francisco, Calif.). "Matrix metalloproteinase substrates and ot... Read More


US Patent Issued to CYTOMX THERAPEUTICS on July 14 for "Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof" (California, Colorado Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,899, issued on July 14, was assigned to CYTOMX THERAPEUTICS INC. (South San Francisco, Calif.). "Matrix metalloproteinase substrates and ot... Read More


US Patent Issued to BIOSION on July 14 for "Antibodies binding RANKL and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,900, issued on July 14, was assigned to BIOSION INC. (Nanjing, China). "Antibodies binding RANKL and uses thereof" was invented by Mingjiu ... Read More


US Patent Issued to BioLegend on July 14 for "Anti-TLR7 agents and compositions and methods for making and using the same" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,901, issued on July 14, was assigned to BioLegend Inc. (San Diego). "Anti-TLR7 agents and compositions and methods for making and using the... Read More


US Patent Issued to SHINSHU UNIVERSITY, KYOTO PREFECTURAL PUBLIC UNIVERSITY, BRIGHTPATH BIOTHERAPEUTICS on July 14 for "Method for producing cell population containing CAR-expressing immune cells" (Japanese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,902, issued on July 14, was assigned to SHINSHU UNIVERSITY (Nagano, Japan), KYOTO PREFECTURAL PUBLIC UNIVERSITY Corp. (Kyoto, Japan) and BRI... Read More